# Topical Aluminium Chloride vs OnabotulinumtoxinA Intradermal Injections in Residual Limb Hyperhidrosis (Lower Limbs)

> **NCT03433859** · PHASE3 · COMPLETED · sponsor: **Direction Centrale du Service de Santé des Armées** · enrollment: 54 (actual)

## Conditions studied

- Hyperhidrosis
- Residual Limbs

## Interventions

- **DRUG:** OnabotulinumtoxinA
- **OTHER:** Topical Aluminium Chloride (cosmetic product)

## Key facts

- **NCT ID:** NCT03433859
- **Lead sponsor:** Direction Centrale du Service de Santé des Armées
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2020-09-10
- **Final completion:** 2021-03-03
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03433859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03433859, "Topical Aluminium Chloride vs OnabotulinumtoxinA Intradermal Injections in Residual Limb Hyperhidrosis (Lower Limbs)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03433859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*